Abstract
Arising from: R. W. Snow, C. A. Guerra, A. M. Noor, H. Y. Myint & S. I. Hay Nature 434, 214–217 (2005); see also communication from Bell; Snow et al. reply.
Estimates of the disease burden caused by malaria are crucial for informing malaria control programmes. Snow and colleagues claim that their estimate of 515 million cases of malaria caused by Plasmodium falciparum globally is up to 50% higher than that reported by the World Health Organization (WHO), and 200% higher for areas outside Africa1. However, this comparison refers to the WHO's estimates from 1990 and 1998, and not to the range of 300 million to 500 million that the WHO has used since 2000 (ref. 2). Both groups agree that the burden of malaria disease outside Africa, especially in South Asia, is greater than was estimated in the 1990s.
Similar content being viewed by others
Main
A new global map of populations living at risk of malaria transmission, produced in 2004 and funded in part by the WHO's Roll Back Malaria department (WHO/RBM), forms the basis of new estimates both by Snow and colleagues1 and the WHO/RBM3. Both current sets of estimates reflect the consensus that cases recorded and reported in national health information systems capture far less than the full burden of malaria in most parts of the world.
In October 2004, a group of independent experts reviewed the WHO/RBM's new estimation method and concluded that, even with the best available data, it is preferable to present any malaria incidence estimate as a range4. An important reason for this conclusion is that the research studies used as input are normally conducted in areas where malaria transmission is greatest, and during the season of peak malaria transmission. Extrapolation from these studies may therefore result in a picture that is not truly representative of the entire region. In addition, the population-at-risk map may not be totally accurate, given fluctuations in malaria transmission patterns in response to environmental change, development and vector control4.
The WHO's global burden estimate for 2004 of 350 million to 500 million cases, of which 270 million to 400 million are due to infection by P. falciparum3, is generally consistent with the 300 million to 660 million range for P. falciparum proposed by Snow and colleagues1. The somewhat smaller range estimated by the WHO is likely to be due to our inclusion of the impact of preventive interventions (insecticide-treated mosquito nets and indoor residual spraying), the coverage of which has increased since 2000. Further, for selected areas with highly unstable malaria transmission, the WHO's estimate takes into account case numbers reported through routine health information systems, which often reflect both passive and active case detection and, in these settings, may provide a more reliable and up-to-date picture than extrapolations made from published research in sometimes distant sites.
The WHO is working with countries to improve their capacity for collecting the data required for future national-level incidence estimates. Data will be obtained from national surveys and sentinel surveillance sites, as well as from health information systems. These efforts should improve the precision of burden estimates at all levels and allow us to assess, in the second half of this decade, whether the ongoing increase in coverage of effective prevention and treatment measures are bringing us closer to the global goal of reducing the burden of malaria by half by the year 2010.
References
Snow, R. W., Guerra, C. A., Noor, A. M., Myint, H. Y. & Hay, S. I. Nature 434, 214–217 (2005).
WHO Expert Committee on Malaria: 20th Report (World Health Organization, Geneva, 2000). http://www.rbm.who.int/docs/ecr20.pdf
Korenromp, E. L. for the RBM MERG Task Force on Malaria Morbidity: Malaria Incidence Estimates at Country Level for the Year 2004 — Proposed Estimates and Draft Report (World Health Organization, Roll Back Malaria, Geneva, 2005). http://mosquito.who.int/docs/incidence_estimations2.pdf
Minutes of the First MERG Task Force Meeting on Malaria Morbidity (World Health Organization, Roll Back Malaria, Geneva, 2004). http://rbm.who.int/partnership/wg/wg_monitoring/docs/MorbidityTaskForce_meetingOct04_2004.pdf.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nahlen, B., Korenromp, E., Miller, J. et al. Estimating clinical episodes of malaria. Nature 437, E3 (2005). https://doi.org/10.1038/nature04178
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature04178
This article is cited by
-
Biotechnological approaches for artemisinin production in Artemisia
World Journal of Microbiology and Biotechnology (2018)
-
Detecting mutations in PfCRT and PfMDR1 genes among Plasmodium falciparum isolates from Saudi Arabia by pyrosequencing
Parasitology Research (2011)
-
Implementation of Home based management of malaria in children reduces the work load for peripheral health facilities in a rural district of Burkina Faso
Malaria Journal (2008)
-
Comparative genome analysis reveals a conserved family of actin-like proteins in apicomplexan parasites
BMC Genomics (2005)
-
Estimating clinical episodes of malaria (reply)
Nature (2005)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.